Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
NCT ID: NCT01937312
Eligibility Criteria: Inclusion Criteria: * Diagnosis of open angle glaucoma (including open-angle glaucoma with pseudoexfoliation or pigment dispersion) or ocular hypertension; * Mean intraocular pressure (IOP) measurements in at least 1 eye (study eye) of ≥ 21 mmHg and \<32 mmHg at 2 consecutive visits (Eligibility 1 and Eligibility 2); * Previously prescribed TRAVATAN Z® 0.004%, XALATAN® 0.005%, or LUMIGAN® 0.01% monotherapy for at least 28 days prior to the Screening Visit; * Able to understand and sign Informed Consent Document; * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Women of childbearing potential who are pregnant, breastfeeding, or do not agree to use an adequate birth control method throughout the study; * Any form of glaucoma other than open angle glaucoma or ocular hypertension; * Severe central visual field loss; * Chronic, recurrent, or severe inflammatory eye disease; * Ocular trauma within the past 6 months; * Ocular infection or ocular inflammation within the past 3 months; * Best-corrected visual acuity score worse than approximately 20/80 Snellen; * Eye surgery within the past 6 months; * Any condition, including severe illness, which would make the subject unsuitable for the study in the opinion of the Investigator; * Use of any additional topical or systemic ocular hypertensive medication during the study; * Patients who, in the opinion of the Investigator, cannot discontinue all IOP-lowering ocular medication(s) per the appropriate washout schedule prior to Eligibility 1 Visit; * Other protocol-defined exclusion criteria may apply.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT01937312
Study Brief:
Protocol Section: NCT01937312